Evonik API production plant underway in China
Specialty chemicals producer Evonik Industries has held the groundbreaking ceremony for its active pharmaceutical ingredients plant at Evonik Rexim (Nanning) Pharmaceutical Co Ltd in China.
Specialty chemicals producer Evonik Industries has held the groundbreaking ceremony for its active pharmaceutical ingredients plant at Evonik Rexim (Nanning) Pharmaceutical Co Ltd in China.
Evonik Rexim (Nanning) Pharmaceutical was originally established by Evonik (previously known as Degussa) and its local partners in 2001. In 2005, Evonik Rexim became a wholly owned subsidiarys of Evonik Industries. The company now has around 300 employees. Its main products are cGMP controlled pharmaceutical amino acids for the domestic and for export markets.
The new cGMP amino acid derivatives plant will produce large scale APIs for global pharmaceutical customers. Evonik Degussa has been chosen as a supplier under a long-term contract because it has custom manufacturing assets in Europe and in China. This gives the customers a combination of a competitive cost position, an excellent track record in audits by Western and Chinese health authorities, and IP protection systems, says the company.
The new plant is scheduled to be in operation by the fourth quarter of 2009. The investment will provide approximately 100 jobs in Nanning.